No. 23-5822

Gina Russomanno v. Sunovion Pharmaceuticals Inc., et al.

Lower Court: Third Circuit
Docketed: 2023-10-17
Status: Denied
Type: IFP
Response WaivedIFP
Tags: appeals appellate-procedure civil-procedure due-process federal-rules-of-civil-procedure frcp-rules jurisdiction jurisdiction-statement motion-for-permission pro-se rule-54b standing
Key Terms:
Environmental SocialSecurity Securities Immigration
Latest Conference: 2023-12-08
Question Presented (AI Summary)

Whether the Supreme Court will consider the merits of the decision by the U.S. Court of Appeals for the Third Circuit

Question Presented (from Petition)

QUESTIONS FOR REVIEW | Whether, the Supreme Court will consider the merits of the decision by the U.S. Court of Appeals for the Third Circuit, pursuant to Pro Se plaintiffs Direct Motion upon the Court of Appeals for the Third Circuit, for Permission to Appeal Case [3:19-cv-05945], by FRAP | ) Rule 5(a); FRCP Rules 60(b)(6); Rule 60(d)(1); and Rule ; 54(b); requesting permission from the Court of Appeals, via ‘plaintiff-stated,’ Jurisdiction Statement, (Document 1-1, pg. 6-8, in case action [23-8013]). See:

Docket Entries

2023-12-11
Petition DENIED.
2023-11-27
Application (23A374) denied by Justice Alito.
2023-11-22
DISTRIBUTED for Conference of 12/8/2023.
2023-11-15
Waiver of right of respondent Sunovion Pharmaceuticals Inc. to respond filed.
2023-11-06
Waiver of right of respondent IQVIA Inc. to respond filed.
2023-10-05
Petition for a writ of certiorari and motion for leave to proceed in forma pauperis filed. (Response due November 16, 2023)
2023-10-05
Application (23A374) for a stay, submitted to Justice Alito.
2023-08-24
Application (23A158) granted by Justice Alito extending the time to file until November 6, 2023.
2023-08-16
Application (23A158) to extend the time to file a petition for a writ of certiorari from September 6, 2023 to November 5, 2023, submitted to Justice Alito.

Attorneys

Gina Russomanno
Gina Russomanno — Petitioner
Gina Russomanno — Petitioner
IQVIA Inc.
Andrew Ronald SperlDuane Morris LLP, Respondent
Andrew Ronald SperlDuane Morris LLP, Respondent
Sunovion Pharmaceuticals Inc.
Ivan Ross NovichLittler Mendelson, P.C., Respondent
Ivan Ross NovichLittler Mendelson, P.C., Respondent